Bülent Karabulut

6PUBLICATIONS
82CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|Aug 30, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.

Ahmet Özet, Faysal Dane, Nuri Faruk Aykan

|Apr 19, 2019
Evaluation of sarcopenia, sarcopenic obesity, and phase angle in geriatric gastrointestinal cancer patients: before and after chemotherapy

Derya Hopancı Bıçaklı, Rüksan Çehreli, Ahmet Özveren

|Oct 06, 2018
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.

Burcu Çakar, Zeki Sürmeli, Pınar Gürsoy Öner

Pageof 1

Frequent Collaborators

2 joint publications

İlker Nihat Ökten

2 joint publications

Tuba Baydaş

2 joint publications

İrfan Çiçin

1 joint publications

Hacı Mehmet Türk